Nutrition
Health
Researchers at Weill Cornell Medicine have developed two engineered strains of mycobacteria with “kill switches” that can be activated to stop bacterial activity after eliciting an immune response. This breakthrough aims to enhance tuberculosis (TB) vaccination efforts and overcome safety challenges in designing bacteria for controlled human infection trials or improved vaccines.
Articles
As the fall season approaches, whether or not you have the typical back-to-school routines or experience the changing weather, there…